All Type of News
Celltrion makes KRW 263.4 billion sales in 2nd quarter
On the 8th, Celltrion gave a notice about the company’s 2018 2nd quarter consolidated business performance that they had a 7% increase to KRW 263.4 billion sales, but a 21.7% decrease to KRW 108.2 billion operating pr...
Pharmacy society has a hard time when returning Chinese ‘Valsaltan’ ingredients
In a process of exchanging drugs containing Valsartan ingredients with carcinogenic factors, pharmacies are having trouble with patients over calculating patient-sharing expenses.
According to the pharmacy society, b...
Orphan drugs in development
Under the Orphan Drug Program enforced in 2013, total 18 products have been designated since the year.
According to the Ministry of Health and Welfare(MFDS), the government has introduced and enforced the Orphan Drug...
Samsung Group, “We’ll make biopharmaceutical field as the next semiconductor business”
Samsung Group will start to aggressively invest funds to make the biologic field to the next semiconductor business.
On the 8th, Samsung announced plans to invest total KRW 180 trillion for the next 3 years to contin...
“We accept necessity of adding antacids into the emergency household medicines list”
As necessity of adding antacids in the list of emergency household medicines is accepted, they will discuss about which specific products to add in the list.
The Ministry of Health and Welfare(Minister Neung-Hoo Park...
Obligation to submit written statement for no response to medical dispute mediation
A bill will be introduced to turn in a written statement for not responding to a medical dispute mediation.
The Minjoo Party Rep. Sang-Hee Kim representatively tabled the ‘Partial Revision Bill to the Medical Inciden...
Organization of Legalizing Medical Cannabis in Korea founds Korea Cannabinoid Association
The Organization of Legalizing Medical Cannabis in Korea, which had the foundation meeting in 2017, will found the ‘Korea Cannabinoid Association,’ a non-governmental organization, at Patriot Ahn Jung Geun Memorial Ha...
Celltrion starts Phase I and Phase III clinical trials for Humira biosimilar
Celltrion recently announced that they made a clinical trial application for ‘CT-P17,’ a biosimilar referencing the rheumatoid arthritis therapy ‘Humira(generic name: adalimumab),’ to the U.K. Medicines and Healthcare...
MFDS extensively develop QbD mode to raise competitiveness of pharma industry
The Ministry of Food and Drug Safety(MFDS) will extensively develop the ‘Quality by Design(QbD) system’ model to strengthen completeness of the Korean pharmaceutical industry.
Quality by Design, a new paradigm in dru...
‘Final meeting’ for emergency household medicines starts finally
The final meeting arranged to adjust emergency household medicine products was held after the long postponement for 1 year and 6 months.
The Ministry of Health and Welfare(MOHW) held the ‘6th Deliberative Committee f...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
